Abstract
This study investigated fiber-type-specific muscle ceramide content in obese subjects and type 2 diabetes patients. Two substudies, one which compared type 2 diabetes patients to both lean- and obese BMI-matched subjects and the other study which compared lean body–matched post-obese, obese, and control subjects, were performed. A fasting blood sample was obtained and plasma insulin and glucose determined. A muscle biopsy was obtained from deltoideus and vastus lateralis, and fiber-type ceramide content was determined by fluorescence immunohistochemistry. Insulin sensitivity estimated by Quicki index was higher in lean compared to type 2 diabetes patients and obese controls. Also in control and post-obese subjects, a higher insulin sensitivity was observed compared to obese subjects. Ceramide content was consistently higher in type I than in type II muscle fibers and higher in deltoideus than vastus lateralis across all groups. No significant differences between groups were observed in ceramide content in either of the two substudies. In human skeletal muscle, ceramide content was higher in type I than in type II fibers in patients with type 2 diabetes and in obese subjects, but overall ceramide muscle fiber content was not different compared to controls.
Similar content being viewed by others
References
Kraegen EW, Cooney GJ, Turner N (2008) Muscle insulin resistance: a case of fat overconsumption, not mitochondrial dysfunction. Proc Natl Acad Sci USA 105:7627–7628
Corpeleijn E, Hessvik NP, Bakke SS, Levin K, Blaak EE, Thoresen GH, Gaster M, Rustan AC (2010) Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids. Am J Physiol Endocrinol Metab 299:E14–E22
Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42–72
Adams JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25–31
Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, Zabielski P, Adamska A, Blachnio A, Gorski J, Gorska M (2007) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50:2366–2373
Coen PM, Dube JJ, Amati F, Stefanovic-Racic M, Ferrell RE, Toledo FG, Goodpaster BH (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59:80–88
Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJ, Dyck DJ (2006) Endurance training in obese humans improves glucose tolerance, mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 291:E99–E107
Dube JJ, Amati F, Toledo FG, Stefanovic-Racic M, Rossi A, Coen P, Goodpaster BH (2011) Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia 54:1147–1156
Skovbro M, Baranowski M, Skov-Jensen C, Flint A, Dela F, Gorski J, Helge JW (2008) Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia 51:1253–1261
Helge JW, Dobrzyn A, Saltin B, Gorski J (2004) Exercise and training effects on ceramide metabolism in human skeletal muscle. Exp Physiol 89:119–127
Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP (2007) Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab 92:1524–1529
Helge JW, Stallknecht B, Drachmann T, Hellgren LI, Jimenez–Jimenez R, Andersen JL, Richelsen B, Bruun JM (2011) Improved glucose tolerance after intensive life style intervention occurs without changes in muscle ceramide or triacylglycerol in morbidly obese subjects. Acta Physiol (Oxf) 201:357–364
Nordby P, Prats C, Kristensen D, Ekroos K, Forsberg G, Andersen JL, Ploug T, Dela F, Storlien L, Helge JW (2010) Muscle ceramide content in man is higher in type I than type II fibers and not influenced by glycogen content. Eur J Appl Physiol 109:935–943
Larsen S, Ara I, Rabol R, Andersen JL, Boushel R, Dela F, Helge JW (2009) Are substrate use during exercise and mitochondrial respiratory capacity decreased in arm and leg muscle in type 2 diabetes? Diabetologia 52:1400–1408
Ara I, Larsen S, Stallknecht B, Guerra B, Morales-Alamo D, Andersen JL, Ponce-Gonzalez JG, Guadalupe-Grau A, Galbo H, Calbet JA, Helge JW (2011) Normal mitochondrial function and increased fat oxidation capacity in leg and arm muscles in obese humans. Int J Obes (Lond) 35:99–108
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410
Stefanini M, De MC, Zamboni L (1967) Fixation of ejaculated spermatozoa for electron microscopy. Nature 216:173–174
Dobrzyn A, Gorski J (2002) Effect of acute exercise on the content of free sphinganine and sphingosine in different skeletal muscle types of the rat. Horm Metab Res 34:523–529
Dobrzyn A, Zendzian-Piotrowska M, Gorski J (2004) Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat. J Physiol Pharmacol 55:305–313
Malenfant P, Tremblay A, Doucet E, Imbeault P, Simoneau JA, Joanisse DR (2001) Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol 280:E632–E639
He J, Watkins S, Kelley DE (2001) Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50:817–823
Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025
Cuschieri J, Bulger E, Billgrin J, Garcia I, Maier RV (2007) Acid sphingomyelinase is required for lipid Raft TLR4 complex formation. Surg Infect (Larchmt) 8:91–106
Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, Pagliassotti MJ, Scherer PE, Summers SA (2011) Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 121:1858–1870
Kim TH, Choi SE, Ha ES, Jung JG, Han SJ, Kim HJ, Kim DJ, Kang Y, Lee KW (2011) IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetol [Epub ahead of print]
Kern M, Wells JA, Stephens JM, Elton CW, Friedman JE, Tapscott EB, Pekala PH, Dohm GL (1990) Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level. Biochem J 270:397–400
James D, Jenkins A, Kraegen E (1985) Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol 248:E567–E574
Kelley DE, Simoneau J-A (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349–2356
Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG, Dohm GL (1995) Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol 268:E453–E457
Helge JW, Kriketos AD, Storlien LH (1998) Insulin sensitivity, muscle fibre types and membrane lipids. In: Richter EA (ed) Skeletal muscle metabolism in exercise and diabetes, 441st edn. Plenum Press, New York, pp 129–138
Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Kinalska I, Baranowski M, Zendzian-Piotrowska M, Brzezinska Z, Gorski J (2004) Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 53:1215–1221
Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005–2011
Vistisen B, Hellgren L, Vadset T, Scheede-Bergdahl C, Helge JW, Dela F, Stallknecht B (2008) Effect of gender on lipid-induced insulin resistance in obese subjects. Eur J Endocrinol 158:61–68
Helge JW, Tobin L, Drachmann T, Hellgren LI, Dela F, Galbo H (2012) Muscle ceramide content is similar after 3 weeks’ consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes. Eur J Appl Physiol 112:911–918
Lipina C, Hundal HS (2011) Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance. Diabetologia 54:1596–1607
Acknowledgments
Financial support was received from the Velux Foundation, the Lundbeck Foundation, the Novo Nordisk Foundation, The Foundation of 1870, Direktør Jacob and Olga Madsens Foundation, Aase and Ejnar Danielsens foundation, and Astra Zeneca. Furthermore, we thank Jesper Isager Sally, Thomas Beck, Jeppe Bach, and Regitze Kraunsøe (all Dept. Biomedical Sciences, University of Copenhagen) for providing excellent technical assistance. In addition, we thank Assoc. Prof. Bente Stallknecht (Dept. Biomedical Sciences, University of Copenhagen) for performing the biopsies in the Post-obese study.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Massimo Federici.
Rights and permissions
About this article
Cite this article
Kristensen, D., Prats, C., Larsen, S. et al. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus. Acta Diabetol 50, 705–712 (2013). https://doi.org/10.1007/s00592-012-0379-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-012-0379-0